The largest database of trusted experimental protocols

Proteus mirabilis

Sourced in China, Italy, United Kingdom, Malaysia, United States

Proteus mirabilis is a bacterial strain available from the American Type Culture Collection. It is a gram-negative, rod-shaped bacterium that is commonly found in the human gastrointestinal tract and the environment. The strain is maintained for research and study purposes.

Automatically generated - may contain errors

55 protocols using proteus mirabilis

1

Antibacterial Potential of Natural Compounds

Check if the same lab product or an alternative is used in the 5 most similar protocols
Six bacteria strains were used to examine the antibacterial properties of the test samples; four Gram-negative [Escherichia coli (ATCC 25922), Klebsiella pneumoniae (ATCC 13883), Proteus mirabilis (ATCC 43071), Pseudomonas aeruginosa (ATCC 10145)] and two Gram-positive [Staphylococcus aureus (ATCC 25923) and Staphylococcus epidermidis (ATCC 12228)]. All bacteria strains were obtained from UCSI University, Kuala Lumpur Campus (South Wing). All chemicals and solvents used were of analytical or HPLC grade. Gallic acid was purchased from Merck (Germany). (+)-Catechin were purchased from Sigma-Aldrich (USA) and kaempferol were obtained from EMD Millipore (USA). HPLC grade methanol was obtained from Fluka (USA) and ultra-pure water was produced from the Mili-Q water purification system (18 m′Ω cm, Merck Millipore, USA).
+ Open protocol
+ Expand
2

Evaluating Antimicrobial Activities

Check if the same lab product or an alternative is used in the 5 most similar protocols
Standard isolates of different bacteria strains: American Type Culture Collection (ATCC)
including Staphylococcus aureus (ATCC 25923), Escherichia
coli
(ATCC 25922), Salmonella typhi (ATCC 13062),
Shigella flexneri (ATCC 12022), Pseudomonas aeruginosa(ATCC 27853), and Proteus mirabilis (ATCC 29906) were obtained from the
Ethiopian Public Health Institute (Addis Ababa, Ethiopia). The bacteria were purposely
selected for evaluating the spectrum of activity and considering the folkloric repute of
the experimental plants.
+ Open protocol
+ Expand
3

Antibacterial Activity of Plant Extracts

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antibacterial activity of all extracts was tested against four strains of Gram-positive bacteria (Staphylococcus epidermidis ATCC 12228, Staphylococcus aureus ATCC 25923, Bacillus cereus ATCC 11778, and Listeria monocytogenes NIPH-NIH 17/11) and eight strains of Gram-negative bacteria (Yersinia enterocolitica O3 NIPH-NIH 383/11, Pseudomonas aeruginosa ATCC 27853, Klebsiella pneumoniae ATCC 13883, Proteus mirabilis ATCC 35659, Shigella sonnei NIPH-NIH, Salmonella enterica subsp. enterica serovar Enteritidis ATCC 13076, Enterobacter aerogenes ATCC 13048, and Escherichia coli ATCC 25922).
The strains were obtained from the American Type Culture Collection (ATCC, Manassas, VA, USA), and clinical isolates from the National Institute of Public Health—National Institute of Hygiene (NIPH—NIH, Warsaw, Poland).
The bacterial strains were cultured on nutrient agar for 24 h at 37 °C. The inocula were diluted to approximately 1 × 108 cfu/mL using 0.85% NaCl (w/v).
+ Open protocol
+ Expand
4

Antimicrobial Susceptibility Testing Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
The reference strains of microorganisms from American Type Culture Collection (ATCC), Manassas, VA, USA, were included. The representative Gram-positive bacteria were: Staphylococcus aureus ATCC 6538, Staphylococcus aureus ATCC 25923, Staphylococcus epidermidis ATCC 12228, Micrococcus luteus ATCC 10240, Bacillus subtilis ATCC 6633 and Bacillus cereus ATCC 10876, while those of Gram-negative bacteria: Escherichia coli ATCC 25922, Proteus mirabilis ATCC 12453, Klebsiella pneumoniae ATCC 13883, Salmonella Typhimurium ATCC 14028, Pseudomonas aeruginosa ATCC 9027 and Bordetella bronchiseptica ATCC 4617. Moreover, the fungi belonging to yeasts (Candida albicans ATCC 2091, Candida albicans ATCC 10231, Candida parapsilosis ATCC 22019, Candida glabrata ATCC 90030 and Candida krusei ATCC 14243) were used.
+ Open protocol
+ Expand
5

Antimicrobial Activity Screening Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The microdilution method was used to determine the antimicrobial activity according to the European Committee on Antimicrobial Susceptibility Testing [20 ]. MH broth and MH broth with 2% glucose were used to grow the bacteria and yeasts, respectively. The following microbial strains were tested: Bacillus subtilis ATCC 6633, Candida albicans ATCC 2091, Candida glabrata ATCC 90030, Candida parapsilosis ATCC 22019, Enterococcus faecalis ATCC 29212, Escherichia coli ATCC 25922, Klebsiella pneumoniae ATCC 13883, Micrococcus luteus ATCC 10240, Proteus mirabilis ATCC 12453, Pseudomonas aeruginosa ATCC 90271, Salmonella Typhimurium ATCC 14028, Staphylococcus aureus ATCC 25923, Staphylococcus aureus ATCC BAA-1707 (methicillin-resistant strain), and Staphylococcus epidermidis ATCC 12228. The minimum inhibitory concentration (MIC) was calculated and reported for each sample and strain. All experiments were performed in triplicate.
+ Open protocol
+ Expand
6

Evaluating Disinfection Efficacy against Nosocomial Pathogens

Check if the same lab product or an alternative is used in the 5 most similar protocols
The standard reference strains used in this study were Escherichia coli (ATCC 8739), Staphylococcus aureus (ATCC 6538), Pseudomonas aeruginosa (ATCC 27853), Enterococcus faecalis (ATCC 29212), Citrobacter freundii (ATCC 43864), Proteus mirabilis (ATCC 29906), Candida albicans (ATCC 18804) and Candida parapsilosis (ATCC 22019), which were obtained from Microbiologics (St. Cloud, Minnesota) or from the Culture Collection of the Institute of Health Sciences, Federal University of Bahia (Universidade Federal da Bahia–UFBA), located in Salvador, Brazil. The selection of test strains was based on studies of microorganisms commonly causing nosocomial infections, as well as on the recommendations of regulatory agencies for evaluating the efficacy of chemical disinfectants [57 (link), 59 (link)–65 (link)]. The suspensions of the test microorganisms were prepared by transferring cells from the pure culture to plates containing 15–20 mL of plate count agar: agar (9 g/L); dextrose (1 g/L); tryptone (5.0 g/L) and yeast extract (2.5 g/L). To evaluate the disinfection profile in the chamber against the test microorganisms, the inocula were prepared by suspending 1–5 colonies in 5 mL of 0.85% saline solution and the turbidity was adjusted to McFarland No. 0.5 tube [66 ].
+ Open protocol
+ Expand
7

Antimicrobial Susceptibility of Clinical and Reference Bacterial Strains

Check if the same lab product or an alternative is used in the 5 most similar protocols
Strains used included clinical isolates Escherichia coli KPC-positive ID N°.181244635 (link), Escherichia coli multiresistant ID N°.210112335 (link) and carbapenemase-producing Klebsiella pneumoniae 1825971 (KPC971), as well as reference strains Bacillus subtilis ATCC 6633, Enterococcus faecalis ATCC 12953, Staphylococcus aureus ATCC 29213, Methicillin-Resistant Staphylococcus aureus ATCC 33591, Streptococcus pyogenes ATCC 19615, Escherichia coli ATCC 8739, Klebsiella pneumoniae ATCC 13885, Proteus mirabilis ATCC 25933, Pseudomonas aeruginosa ATCC 15442 and Salmonella enterica ATCC 14028. Bacteria were plated on brain heart infusion (BHI) agar (Himedia, India) from a frozen stock. Following 24 h incubation, three isolated colonies were transferred to 1 mL of BHI broth. The broth culture was incubated overnight (12–16 h) at 37 °C with shaking36 (link).
+ Open protocol
+ Expand
8

Bacterial Strains for Binding Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The bacterial strain E. coli ATCC 25922 (American Type Culture Collection, Georgetown, DC, USA) was maintained in Luria-Bertani (LB) medium. Whole bacterial cells to be use as targets for selection were cultured at 37°C to a OD600 of 0.3 (equivalent to ~2.4 x 108 bacteria/mL), washed twice with PBS (NaCl2 137 mM, 2.7 mM KCl, 4.3 mM Na2HPO4.7H2O, 1.5 mM KH2PO4) and diluted in selection buffer (PBS containing 1.4 mM MgCl2).
The following bacterial strains were used in binding assays: Klebsiella pneumonia ATCC 27853, Enterobacter aerogenes ATCC 13048, Proteus mirabilis ATCC 00557, Pseudomonas aeruginosa ATCC 700603, Staphylococcus aureus ATCC 29213 and Enterococcus faecalis ATCC 29212, from ATCC; and Enterobacter cloacae, Proteus vulgaris, Morganella morganii, Citrobacter freundii, Acinetobacter baumannii, Enterococcus faecalis, Enterococcus faecium, from the bacterial collection of the Instituto Adolfo Lutz (São Paulo, SP, Brazil). The MNEC clinical isolates used here were obtained from the Clinical Hospital of the Federal University of Paraná (HC, Curitiba, PR, Brazil).
+ Open protocol
+ Expand
9

Antimicrobial Activity of Plant Extract

Check if the same lab product or an alternative is used in the 5 most similar protocols
The antimicrobial activity of the extract of the stem was tested in triplicate,
by the disk diffusion method(7 ), using bacterial and fungal strains standardized and
distributed by the American Type Cell Collection (ATCC). The bacterial strains
tested were Streptococcus pyogenes (ATCC 19615),
Staphylococcus aureus (ATCC 25923), Staphylococcus
epidermidis
(ATCC 12228), Pseudomonas aeruginosa(ATCC 27853), Proteus mirabilis (ATCC 49565),
Klebsiella pneumoniae (ATCC 31488) and Escherichia
coli
(ATCC 14942). As a fungal strain, Candida
albicans
(ATCC 10231) was tested. The minimum inhibitory
concentration (MIC) was determined from the sample which presented activity and
was chosen for continuation of the study, the MIC being defined based on serial
dilutions of the active extract. The experiments were undertaken in
triplicate.
+ Open protocol
+ Expand
10

Diverse Bacterial Species Cultivation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The bacterial species used were Proteus mirabilis (ATCC 29906), Escherichia fergusonii (ATCC 35469), Escherichia coli HB101 (Caenorhabditis Genetics Center), Pseudomonas fluorescens (ATCC 13525), Micrococcus luteus (ATCC 4698), Staphylococcus hominis (ATCC 27844), Rhizobium leguminosarum (ATCC 14479), Raoultella ornithinolytica JUb54 and Raoultella sp. JUb38 (obtained from Samuel lab, Baylor College of Medicine), and Bacteroides thetaiotaomicron (ATCC 29148, obtained from Hsiao lab, UCLA). E. coli, E. fergusonii, P. mirabilis, P. fluorescens, JUb38, and JUb54 were maintained on Luria broth (LB) plates, grown in LB, and diluted in LB. S. hominis and M. luteus were maintained on tryptic soy plates, grown in tryptic soy media, and diluted in tryptic soy media. R. leguminosarum was maintained on Rhizobium X plates, grown in Rhizobium X media, and diluted in Rhizobium X media. B. thetaiotaomicron was cultured anaerobically in brain-heart infusion supplemented media (BHIS) as previously described [70 (link)], and diluted in BHIS. Growth temperatures were 37 °C for all strains except for the Raoultella strains, P. fluorescens, and R. leguminosarum (28 °C); and M. luteus (30 °C). Each species was diluted to 1 × 108–1 × 109 CFU/mL as measured by a Thermo Scientific™ NanoDrop™ One spectrophotometer before use.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!